Castle Biosciences, Inc.
CSTLDiagnostics & Research
$37.16−3.51%As of Oct 30vs prior close
- Market cap
- $1.1B
- P/E (TTM)
- –
- Implied growth
- –
- From 52W high
- −13.66%
- EPS (LTM)
- -$0.64
- Revenue (LTM)
- $357.3M
- Net margin
- -5.43%
Nomior Score
52
Steady ProfileSpeculativeTop 45% of the scored universe
Growth60
Quality47
Value47
Momentum65
Resilience41
Growth
+47.39%revenue a year over 7 fiscal years
YE18 $22.8MLTM $357.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 3% of revenue, narrower by 2 pts on a year.
Who owns it
2funds